United States · Series C startup

Who invested in Venclose

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$27Mraised across 1 round since 2019, from 1 source

Latest round
Series C, $27MDec 2019
Investors
1
See who backed them

The rounds

  1. Dec 2019
    Series C$27M

    Reported by FinSMEsSEC filing: $27M sold, first sale Jul 2019

Founders and team

From the SEC filings it signed: 3 on the team.

  • Jason TurnerExecutive Officeri
  • Jerry GibsonExecutive Officer, Directori
  • Peter OsborneExecutive Officer, Directori

On the board, as filediCharles ChonGreg Vislocky

Everyone who backed them

Ally Bridge GroupPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Venclose as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

SCP Ventures, LLCVC firmPer its own site

Quick answers about Venclose

Who invested in Venclose?

Venclose's investors include Ally Bridge Group.

How much has Venclose raised?

Venclose has raised $27M across 1 round since 2019.

When did Venclose last raise?

Venclose's most recent round was a Series C of $27M in Dec 2019.

What was Venclose's biggest round?

Its most recent round, $27M in Dec 2019, is also its largest on record.

Who backed Venclose first?

Venclose's first round on record, in Dec 2019, was backed by Ally Bridge Group.

What stage is Venclose at?

Venclose's latest named round is a Series C, in Dec 2019.

Where is Venclose based?

Venclose is based in the United States.

Companies like Venclose

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.